Odicino FE[au] - Search Results

Year	Number of Results
2006	2
2007	1
2008	2
2009	1
2010	1
2011	1
2012	1
2015	1
2016	7
2017	3
2021	3
2022	3
2023	0

1

Preeclampsia and late fetal growth restriction.

Marasciulo F, Orabona R, Fratelli N, Fichera A, Valcamonico A, Ferrari F, Odicino FE, Sartori E, Prefumo F. Marasciulo F, et al. Among authors: odicino fe. Minerva Obstet Gynecol. 2021 Aug;73(4):435-441. doi: 10.23736/S2724-606X.21.04809-7. Epub 2021 May 5. Minerva Obstet Gynecol. 2021. PMID: 33949823

2

Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks.

Rizzini N, Fratelli N, Negri B, Odicino FE, Sartori E, Risso FM, Prefumo F, Fichera A. Rizzini N, et al. Among authors: odicino fe. Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:214-218. doi: 10.1016/j.ejogrb.2022.02.021. Epub 2022 Feb 23. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35228093

3

Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders.

Cavalli C, Maggi C, Gambarini S, Fichera A, Santoro A, Grazioli L, Prefumo F, Odicino FE, Fratelli N. Cavalli C, et al. Among authors: odicino fe. J Perinat Med. 2021 Dec 3;50(3):277-285. doi: 10.1515/jpm-2021-0334. Print 2022 Mar 28. J Perinat Med. 2021. PMID: 34854274

4

Risk Assessment in Solitary Fibrous Tumor of the Uterine Corpus: Report of a Case and Systematic Review of the Literature.

Ardighieri L, Palicelli A, Ferrari F, Ragnoli M, Ghini I, Bugatti M, Bercich L, Sartori E, Odicino FE. Ardighieri L, et al. Among authors: odicino fe. Int J Surg Pathol. 2022 Apr;30(2):177-183. doi: 10.1177/10668969211025759. Epub 2021 Jun 28. Int J Surg Pathol. 2022. PMID: 34180727

5

The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines.

Bandiera E, Todeschini P, Romani C, Zanotti L, Erba E, Colmegna B, Bignotti E, Santin AD, Sartori E, Odicino FE, Pecorelli S, Tassi RA, Ravaggi A. Bandiera E, et al. Among authors: odicino fe. Oncol Lett. 2016 Oct;12(4):2493-2500. doi: 10.3892/ol.2016.5008. Epub 2016 Aug 16. Oncol Lett. 2016. PMID: 27698818 Free PMC article.

6

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.

Bignotti E, Ragnoli M, Zanotti L, Calza S, Falchetti M, Lonardi S, Bergamelli S, Bandiera E, Tassi RA, Romani C, Todeschini P, Odicino FE, Facchetti F, Pecorelli S, Ravaggi A. Bignotti E, et al. Among authors: odicino fe. Br J Cancer. 2011 Apr 26;104(9):1418-25. doi: 10.1038/bjc.2011.109. Epub 2011 Apr 5. Br J Cancer. 2011. PMID: 21468050 Free PMC article.

7

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.

Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD. Bignotti E, et al. Among authors: odicino fe. Eur J Cancer. 2010 Mar;46(5):944-53. doi: 10.1016/j.ejca.2009.12.019. Epub 2010 Jan 8. Eur J Cancer. 2010. PMID: 20060709

8

Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.

Todeschini P, Salviato E, Paracchini L, Ferracin M, Petrillo M, Zanotti L, Tognon G, Gambino A, Calura E, Caratti G, Martini P, Beltrame L, Maragoni L, Gallo D, Odicino FE, Sartori E, Scambia G, Negrini M, Ravaggi A, D'Incalci M, Marchini S, Bignotti E, Romualdi C. Todeschini P, et al. Among authors: odicino fe. Cancer Lett. 2017 Mar 1;388:320-327. doi: 10.1016/j.canlet.2016.12.017. Epub 2016 Dec 22. Cancer Lett. 2017. PMID: 28017893

9

Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.

Bignotti E, Calza S, Tassi RA, Zanotti L, Bandiera E, Sartori E, Odicino FE, Ravaggi A, Todeschini P, Romani C. Bignotti E, et al. Among authors: odicino fe. J Cell Mol Med. 2016 Dec;20(12):2341-2348. doi: 10.1111/jcmm.12927. Epub 2016 Jul 15. J Cell Mol Med. 2016. PMID: 27419385 Free PMC article.

10

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas.

Bignotti E, Ravaggi A, Tassi RA, Calza S, Rossi E, Falchetti M, Romani C, Bandiera E, Odicino FE, Pecorelli S, Santin AD. Bignotti E, et al. Among authors: odicino fe. Br J Cancer. 2008 Sep 2;99(5):768-73. doi: 10.1038/sj.bjc.6604546. Br J Cancer. 2008. PMID: 18682706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results